New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

However, monotherapy with oncolytic viruses (OVs) has shown limited success ... QED Therapeutics, Incyte, Puma Biotechnology, Adaptimmune, Merck Serono, RedHill Biopharma, Basilea ...

who is a biochemist at the University of Bonn’s IMBIO institute (Institute of Molecular Physiology and Biotechnology of Plants). “The bacteria settle on the surface of the oil droplets ...

Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responses New ...

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype ...

Biomarkers' may help to improve detection and treatment of gastrointestinal diseases such as gastric cancer, colorectal cancer, and inflammatory bowel disease.

Approximately 90% of all kidney cancers involve renal cell carcinoma, against which researchers are racing to find more effective therapies. One of the major challenges in treating this and other ...

Earlier studies demonstrated that the Lister strain of oncolytic vaccinia virus (VVL) is capable of replicating and delivering therapeutic genes even under hypoxic conditions, highlighting its ...

The microbes in the human gut can have a powerful effect on our health and well-being, as many studies have shown in recent years... | Microbiology ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Pelareorep featured in Key Opinion Leader event on oncolytic immunotherapies in breast ... an extremely challenging indication. Oncolytics Biotech Inc shares T.ONC are trading unchanged at $0 ...